Open Access

Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation

Delia Dima

Delia Dima

Search for this author on
Sciendo|Google Scholar
Dima, Delia
, 
Adrian P. Trifa

Adrian P. Trifa

Search for this author on
Sciendo|Google Scholar
Trifa, Adrian P.
, 
Mariana Paţiu

Mariana Paţiu

Search for this author on
Sciendo|Google Scholar
Paţiu, Mariana
, 
Cristian S. Vesa

Cristian S. Vesa

Search for this author on
Sciendo|Google Scholar
Vesa, Cristian S.
, 
Ioana C. Frinc

Ioana C. Frinc

Search for this author on
Sciendo|Google Scholar
Frinc, Ioana C.
, 
Ljubomir Petrov

Ljubomir Petrov

Search for this author on
Sciendo|Google Scholar
Petrov, Ljubomir
 and 
Andrei Cucuianu

Andrei Cucuianu

Search for this author on
Sciendo|Google Scholar
Cucuianu, Andrei
  
Aug 08, 2013
Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Published Online: Aug 08, 2013
Page range: 29 - 37
DOI: https://doi.org/10.2478/rrlm-2013-0015
Keywords
This content is open access.
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Life Sciences, Molecular Biology, Biochemistry, Human Biology, Microbiology and Virology
Journal RSS Feed